+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Acetamiprid Original Drug Market by Form (Soluble Granules, Suspension Concentrate, Wettable Powder), Crop Type (Cereals and Grains, Fruits and Vegetables, Oilseeds and Pulses), Application Method, Mode of Sale - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121126
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Acetamiprid has emerged as a cornerstone in modern crop protection, distinguished by its systemic activity and targeted efficacy against sap-feeding pests. As a member of the neonicotinoid class, this active ingredient offers a favorable toxicological profile for non-target organisms while delivering robust control of aphids, whiteflies, and other persistent agricultural adversaries. Its water solubility and translaminar movement enable effective distribution within plant tissues, ensuring both foliar and root-level protection.

The introduction of acetamiprid into integrated pest management programs signaled a shift toward solutions that balance high performance with environmental stewardship. Its compatibility with beneficial insects and reduced volatilization risk align with the growing demand for sustainable agricultural practices. Producers seeking to mitigate yield losses amid intensifying pest pressures have increasingly adopted acetamiprid as part of a comprehensive strategy that includes crop rotation, biological control agents, and digital monitoring platforms.

Consequently, the global acetamiprid market reflects a convergence of agronomic necessity and regulatory evolution. This section lays the groundwork for understanding how the active ingredient’s physicochemical properties, mode of action, and alignment with eco-friendly paradigms have positioned it as a pivotal tool for growers and agrochemical companies worldwide.

Unraveling the Transformative Shifts in Agricultural Pest Management and Regulatory Dynamics Shaping the Acetamiprid Landscape Globally

The landscape of insecticide development has witnessed profound transformation driven by environmental regulations, resistance management, and technological innovation. Over the past decade, regulatory bodies across major agricultural regions have tightened restrictions on certain classes of chemistries, prompting a shift toward molecules with improved selectivity and lower ecological footprints. Acetamiprid’s favorable risk assessment outcomes have distinguished it among alternatives, catalyzing its adoption in markets that have phased out or limited older neonicotinoids.

Concurrent advances in formulation technology have further enhanced acetamiprid’s market appeal. Novel microencapsulation techniques and suspension concentrate platforms have improved handling safety, extended field persistence, and optimized droplet deposition during application. Digital agriculture tools, including precision sprayers and remote sensing, have amplified these gains by ensuring uniform coverage and reducing overapplication.

Moreover, heightened awareness of pollinator health has spurred research into mitigation strategies that allow continued use of neonicotinoids under stewardship guidelines. Risk mitigation measures such as controlled application timing, buffer zones, and seed coatings have been integrated into product labels to maintain compliance and safeguard biodiversity. These dynamic shifts underscore the transformative context shaping acetamiprid’s trajectory as both an effective pest control agent and a regulatory-compliant solution.

Assessing the Cumulative Impact of United States Tariffs Implemented in 2025 on Acetamiprid Supply Chains Pricing and Market Accessibility

In 2025, the United States enacted revised tariff schedules affecting a range of agrochemical imports, including shipments containing acetamiprid. These duties, implemented in response to domestic industry lobbying and geopolitical considerations, have raised import costs for key raw materials and formulated products originating from major manufacturing hubs. As a direct consequence, supply chain stakeholders have experienced margin compression and upward pressure on retail pricing.

Importers and formulators have responded by reconfiguring sourcing strategies, exploring domestic synthesis partnerships, and negotiating long-term agreements with alternative suppliers in regions less affected by tariff differentials. While such measures have mitigated some cost escalation, the increased complexity in logistics and inventory management has introduced new operational risks. Carriers and distributors report longer lead times and higher financing costs due to the tariffs’ impact on cash flow.

Despite these challenges, certain market segments have absorbed the cost changes more effectively. Premium crops with high per-acre value and integrated service offerings have justified price adjustments, whereas commodity-driven segments have pursued cost-sharing arrangements or switched to competitive insecticidal classes where feasible. The net effect of the 2025 tariff adjustments has been a rebalancing of market dynamics, with an emphasis on supply chain resilience and strategic supplier relationships.

Dissecting Key Insights from Formulation Crop Type Application Method and Channel Stratification within the Acetamiprid Market

The acetamiprid marketplace is defined by distinct preferences across formulation, crop type, application method, and distribution channel. Formulation diversity spans soluble granules prized for their rapid dissolution, suspension concentrates that facilitate uniform coverage, and wettable powders favored for field mixing flexibility; each format addresses specific agronomic conditions and operator requirements. Meanwhile, crop type segmentation reveals that cereals and grains represent a sizable share, driven by large-scale row cropping operations, whereas fruits and vegetables demand precision dosing to minimize residue risks on high-value produce, and oilseeds and pulses benefit from prophylactic treatments to protect yields during early vegetative stages.

Application method further stratifies usage patterns, with foliar spray applications dominating in broadacre and horticultural settings where immediate contact efficacy is essential. Seed treatments leverage acetamiprid’s systemic mobility to deliver foundational protection, particularly in regions facing early-season pest outbreaks. Soil treatment applications, although less prevalent, provide targeted control in rotations susceptible to soil-dwelling insect pests. Channel segmentation underscores the continued importance of direct sales relationships for large-scale growers seeking tailored agronomic support, while distributor networks facilitate broad reach among mid-tier operations. Online sales channels have emerged as a growth vector, offering streamlined procurement and digital advisory services that appeal to tech-savvy producers.

Revealing Critical Regional Dynamics across the Americas Europe Middle East Africa and Asia Pacific Influencing Acetamiprid Uptake

Regional dynamics exert profound influence on demand drivers, regulatory compliance, and competitive intensity in the acetamiprid sector. In the Americas, strong adoption stems from integrated pest management mandates in major grain-producing nations, with formulators tailoring product labels to local environmental guidelines and stewardship protocols. North American growers leverage advanced application technologies to maximize efficacy, while Latin American producers capitalize on cost-effective formulations that address pest pressures in tropical climates.

Within Europe, the Middle East, and Africa, regulatory alignment with stringent ecotoxicology standards shapes product registration timelines and label restrictions. European markets emphasize rotational chemistries and spray buffer requirements to protect pollinators, while emerging African regions focus on expanding access to professional-grade solutions amid growing infrastructural capacity. In the Middle East, greenhouse production of fruits and vegetables drives demand for precision-controlled applications that minimize residue and support year-round cultivation.

The Asia-Pacific region stands out for its diversity of cropping systems and intensifying pest challenges. Large-scale cereal cultivation in key countries drives volume demand, whereas smallholder fruit and vegetable operations create pockets of specialized use. Evolving distribution models, from traditional agro-dealer networks to digital marketplaces, further define market accessibility and competitive positioning across the region.

Profiling Major Industry Players Driving Innovation Commercial Strategies and Competitive Positioning in the Global Acetamiprid Landscape

Leading agrochemical firms have progressively deepened their acetamiprid portfolios through research collaborations, strategic alliances, and targeted acquisitions. Focused R&D efforts have yielded proprietary formulations with enhanced UV stability and reduced spray drift, bolstering value propositions for end users. Key players have also emphasized digital agronomy support, integrating pest forecasting tools and mobile advisory platforms to differentiate their offerings and foster customer loyalty.

Commercial strategies vary by competitive positioning, with established multinational corporations leveraging global distribution networks and regulatory expertise to expedite market entries. Mid-sized specialists have adopted niche approaches, concentrating on high-value crops or emerging markets with tailored product registration and localized technical support. Partnerships with local formulators have enabled optimized cost structures and customized label development, particularly in regions facing unique climatic and pest management challenges.

Competitive intensity is further heightened by private-label initiatives among distributors seeking margin uplift and channel partners adopting multi-brand portfolios. Innovative warranty schemes and performance guarantees underscore the emphasis on demonstrating consistent field efficacy, while integrated crop protection bundles combine acetamiprid with complementary modes of action to address resistance management imperatives.

Formulating Actionable Recommendations for Industry Leaders to Navigate Regulatory Pressures Market Volatility and Evolving Agronomic Demands

To thrive amid evolving regulatory regimes and market pressures, companies should prioritize diversified formulation platforms that address both environmental compliance and user convenience. Investments in microencapsulation and slow-release technologies will extend field longevity and reduce operator exposure, enhancing product stewardship credentials. Strengthening partnerships with application equipment manufacturers can further drive adoption of precision spray systems that minimize drift and optimize active ingredient coverage.

Cultivating digital agronomy services is imperative for fostering long-term customer engagement. By integrating pest monitoring algorithms with local weather data, firms can deliver predictive alerts that guide timing and dosage decisions. Such value-added offerings not only reinforce brand differentiation but also generate recurring revenue streams and data-driven insights for continuous product improvement.

Supply chain resilience should be reinforced through multi-source raw material agreements and strategic inventory buffers, mitigating the impacts of tariff fluctuations and logistical disruptions. Engaging in cross-industry consortiums to advocate for balanced regulatory frameworks will help shape policy outcomes that preserve access to essential crop protection tools. Finally, targeted regional expansion strategies, informed by local cropping calendars and stewardship requirements, will unlock growth opportunities while ensuring alignment with sustainability objectives.

Outlining the Rigorous Research Methodology Employed to Ensure Robust Data Validation and Insight Accuracy within the Acetamiprid Study

The research underpinning this acetamiprid market analysis combined primary interviews with leading agronomists, regulatory specialists, and supply chain executives alongside secondary sources comprising peer-reviewed journals, government registries, and proprietary trade data. A multi-tiered validation process ensured consistency across diverse data points, encompassing formulation volumes, application patterns, and regional regulatory statutes.

Quantitative insights were corroborated through triangulation of shipment records, patent filings, and field trial results, while qualitative perspectives emerged from structured expert panels and in-depth consultations with extension service providers. Geographic coverage was calibrated to reflect key production zones and emerging markets, enabling a holistic view of adoption drivers across heterogeneous agricultural contexts.

Analytical models integrated scenario planning to assess tariff impacts and regulatory shifts, leveraging sensitivity testing to evaluate potential supply chain disruptions. Rigorous data governance protocols preserved integrity, with all findings subject to cross-functional review by seasoned research scientists and industry advisors. This methodical approach underpins the report’s reliability and equips stakeholders with actionable, evidence-based strategic direction.

Synthesizing the Key Findings and Strategic Takeaways to Provide Stakeholders with a Comprehensive Perspective on Acetamiprid’s Market Trajectory

This executive summary highlights acetamiprid’s evolution as a high-performance, environmentally considerate insecticide that addresses modern agronomic challenges. Regulatory realignments have benefited its acceptance, while formulation innovations and digital agronomy tools have expanded its practical applications. The 2025 United States tariff adjustments underscored the importance of supply chain agility, prompting strategic sourcing and inventory management adaptations.

Segmentation insights reveal that formulation preferences, crop type applications, dosing techniques, and channel dynamics vary significantly by region, crop value, and operator scale. Regional analysis underscores differential adoption drivers across the Americas, Europe, Middle East, Africa, and Asia-Pacific, with diverse regulatory frameworks and cropping systems influencing strategic focus areas.

Competitive landscapes are characterized by a blend of global industry titans leveraging scale and localization specialists targeting niche high-value segments. Recommended actions revolve around innovation in formulation technology, digital service integration, and resilient supply chain frameworks to capitalize on emerging market openings. Such strategic imperatives will define market leadership and unlock sustainable growth prospects.

Overall, this comprehensive assessment provides a clear roadmap for stakeholders seeking to harness acetamiprid’s full potential amid an increasingly complex agricultural ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Form
    • Soluble Granules
    • Suspension Concentrate
    • Wettable Powder
  • Crop Type
    • Cereals And Grains
    • Fruits And Vegetables
    • Oilseeds And Pulses
  • Application Method
    • Foliar Spray
    • Seed Treatment
    • Soil Treatment
  • Mode Of Sale
    • Direct Sales
    • Distributor Sales
    • Online Sales
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Sumitomo Chemical Co., Ltd.
  • Nippon Soda Co., Ltd.
  • Bayer CropScience AG
  • Nanjing Spring & Autumn Biological Technology Co., Ltd.
  • Jiangsu Yangnong Chemical Co., Ltd.
  • Nufarm Limited
  • FMC Corporation
  • Ishihara Sangyo Kaisha, Ltd.
  • Mitsui Chemicals, Inc.
  • Jiangsu Huachang Agrochemicals Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory scrutiny and possible neonicotinoid use restrictions influencing acetamiprid market growth
5.2. Innovations in nanoformulation techniques enhancing acetamiprid delivery efficiency against resistant pests
5.3. Rising demand for ecofriendly crop protection solutions driving acetamiprid adoption in sustainable agriculture
5.4. Impact of integrated pest management programs on acetamiprid application patterns in major crop production regions
5.5. Price volatility of key raw materials affecting acetamiprid manufacturing cost structure and supplier landscape
5.6. Patent expiration of major acetamiprid formulations triggering competitive generics market expansion
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Acetamiprid Original Drug Market, by Form
8.1. Introduction
8.2. Soluble Granules
8.3. Suspension Concentrate
8.4. Wettable Powder
9. Acetamiprid Original Drug Market, by Crop Type
9.1. Introduction
9.2. Cereals and Grains
9.3. Fruits and Vegetables
9.4. Oilseeds and Pulses
10. Acetamiprid Original Drug Market, by Application Method
10.1. Introduction
10.2. Foliar Spray
10.3. Seed Treatment
10.4. Soil Treatment
11. Acetamiprid Original Drug Market, by Mode of Sale
11.1. Introduction
11.2. Direct Sales
11.3. Distributor Sales
11.4. Online Sales
12. Americas Acetamiprid Original Drug Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Acetamiprid Original Drug Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Acetamiprid Original Drug Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sumitomo Chemical Co., Ltd.
15.3.2. Nippon Soda Co., Ltd.
15.3.3. Bayer CropScience AG
15.3.4. Nanjing Spring & Autumn Biological Technology Co., Ltd.
15.3.5. Jiangsu Yangnong Chemical Co., Ltd.
15.3.6. Nufarm Limited
15.3.7. FMC Corporation
15.3.8. Ishihara Sangyo Kaisha, Ltd.
15.3.9. Mitsui Chemicals, Inc.
15.3.10. Jiangsu Huachang Agrochemicals Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ACETAMIPRID ORIGINAL DRUG MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ACETAMIPRID ORIGINAL DRUG MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ACETAMIPRID ORIGINAL DRUG MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ACETAMIPRID ORIGINAL DRUG MARKET: RESEARCHAI
FIGURE 24. ACETAMIPRID ORIGINAL DRUG MARKET: RESEARCHSTATISTICS
FIGURE 25. ACETAMIPRID ORIGINAL DRUG MARKET: RESEARCHCONTACTS
FIGURE 26. ACETAMIPRID ORIGINAL DRUG MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACETAMIPRID ORIGINAL DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SOLUBLE GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SOLUBLE GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CEREALS AND GRAINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CEREALS AND GRAINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FRUITS AND VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FRUITS AND VEGETABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY OILSEEDS AND PULSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY OILSEEDS AND PULSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 61. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 62. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 63. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 64. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 65. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 66. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 67. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 68. CANADA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 69. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 70. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 71. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 72. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 73. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 74. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 75. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 76. MEXICO ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 111. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 112. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 113. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 114. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 115. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 116. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 117. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 118. GERMANY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 119. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 120. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 121. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 122. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 123. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 124. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 125. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 126. FRANCE ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 135. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 136. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 137. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 138. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 139. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 140. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 141. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 142. ITALY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 143. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 144. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 145. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 146. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 147. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 148. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 149. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 150. SPAIN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 175. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 176. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 177. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 178. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 179. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 180. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 181. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 182. DENMARK ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 191. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 192. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 193. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 194. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 195. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 196. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 197. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 198. QATAR ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 199. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 200. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 201. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 202. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 203. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 204. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 205. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 206. FINLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 223. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 224. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 225. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 226. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 227. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 228. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 229. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 230. EGYPT ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 231. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 232. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 233. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 234. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 235. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 236. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 237. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 238. TURKEY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 247. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 250. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 251. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 252. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 253. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 254. NORWAY ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 255. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 256. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 257. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 258. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 259. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 260. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 261. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 262. POLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 282. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 283. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 284. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 285. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 286. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 287. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 288. CHINA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 289. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 290. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 291. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 292. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 293. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 294. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 295. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 296. INDIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 297. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 298. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 299. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 300. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 301. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 302. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 303. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 304. JAPAN ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 327. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2018-2024 (USD MILLION)
TABLE 328. INDONESIA ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY MODE OF SALE, 2025-2030 (USD MILLION)
TABLE 329. THAILAND ACETAMIPRID ORIGINAL DRUG MARKET SIZE, BY FORM, 2018-2024 (USD MILLION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Acetamiprid Original Drug market report include:
  • Sumitomo Chemical Co., Ltd.
  • Nippon Soda Co., Ltd.
  • Bayer CropScience AG
  • Nanjing Spring & Autumn Biological Technology Co., Ltd.
  • Jiangsu Yangnong Chemical Co., Ltd.
  • Nufarm Limited
  • FMC Corporation
  • Ishihara Sangyo Kaisha, Ltd.
  • Mitsui Chemicals, Inc.
  • Jiangsu Huachang Agrochemicals Co., Ltd.